Fig. 4From: Hyaluronan self-agglomerating nanoparticles for non-small cell lung cancer targetingIn vitro drug release studies. In vitro drug release of ISHNs and irinotecan injection. The release of irinotecan hydrochloride was determined at a pH of 7.0. Data are expressed as mean ± SD (n = 3)Back to article page